HomeCompareACNDF vs MRK

ACNDF vs MRK: Dividend Comparison 2026

ACNDF yields 7.32% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACNDF wins by $421.21M in total portfolio value
10 years
ACNDF
ACNDF
● Live price
7.32%
Share price
$0.82
Annual div
$0.06
5Y div CAGR
76.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$421.27M
Annual income
$386,451,094.04
Full ACNDF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ACNDF vs MRK

📍 ACNDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodACNDFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ACNDF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ACNDF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACNDF
Annual income on $10K today (after 15% tax)
$621.95/yr
After 10yr DRIP, annual income (after tax)
$328,483,429.93/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ACNDF beats the other by $328,475,101.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACNDF + MRK for your $10,000?

ACNDF: 50%MRK: 50%
100% MRK50/50100% ACNDF
Portfolio after 10yr
$210.66M
Annual income
$193,230,446.09/yr
Blended yield
91.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ACNDF
No analyst data
Altman Z
1.0
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACNDF buys
0
MRK buys
0
No recent congressional trades found for ACNDF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricACNDFMRK
Forward yield7.32%2.76%
Annual dividend / share$0.06$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR76.8%32.7%
Portfolio after 10y$421.27M$56.8K
Annual income after 10y$386,451,094.04$9,798.13
Total dividends collected$418.63M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ACNDF vs MRK ($10,000, DRIP)

YearACNDF PortfolioACNDF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,994$1,293.66$11,206$366.19+$788.00ACNDF
2$15,397$2,563.72$12,650$502.35+$2.7KACNDF
3$21,913$5,438.14$14,407$694.19+$7.5KACNDF
4$36,235$12,788.34$16,585$967.82+$19.6KACNDF
5$73,713$34,941.62$19,342$1,363.89+$54.4KACNDF
6$196,324$117,451.13$22,913$1,947.19+$173.4KACNDF
7$726,941$516,873.74$27,662$2,823.89+$699.3KACNDF
8$3,940,162$3,162,335.97$34,159$4,173.35+$3.91MACNDF
9$32,537,826$28,321,852.37$43,337$6,308.80+$32.49MACNDF
10$421,266,568$386,451,094.04$56,776$9,798.13+$421.21MACNDF

ACNDF vs MRK: Complete Analysis 2026

ACNDFStock

Ascendas India Trust (a-iTrust) was listed on the Singapore Exchange Securities Trading Limited (SGX-ST) in August 2007 as the first Indian property trust in Asia. Its principal objective is to own income-producing real estate used primarily as business space in India. a-iTrust may also develop and acquire land or uncompleted developments primarily to be used as business space, with the objective of holding the properties upon completion. As at 31 December 2019, a-iTrust's asset under management stands at S$2.1 billion. a-iTrust's portfolio comprises seven world-class IT business parks and one logistics park in India, namely the International Tech Park Bangalore, International Tech Park Chennai and CyberVale in Chennai, CyberPearl, The V and aVance in Hyderabad, aVance in Pune and Arshiya warehouses near Mumbai. a-iTrust is structured as a business trust, offering stable income distributions similar to a real estate investment trust. a-iTrust focuses on enhancing shareholder value by actively managing existing properties, developing vacant land in its portfolio, and acquiring new properties. a-iTrust is managed by Ascendas Property Fund Trustee Pte. Ltd. The trustee-manager is a wholly owned subsidiary of Singapore-listed CapitaLand Limited, one of Asia's largest diversified real estate groups.

Full ACNDF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ACNDF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACNDF vs SCHDACNDF vs JEPIACNDF vs OACNDF vs KOACNDF vs MAINACNDF vs JNJACNDF vs ABBVACNDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.